Evidence map›Paper›PMID 12569363›Full record

ArticleOncogene2003

Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein.

Kristopher K Frese, Siu Sylvia Lee, Darby L Thomas, Isabel J Latorre, Robert S Weiss, Britt A Glaunsinger, Ronald T Javier

Abstract read
In one paragraph

Article in Oncogene, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. E4orf1 SuppressesVaccines · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Emerging translation strategies during virus-host interaction.Wiley interdisciplinary reviews. RNA · 2021
    Review
  13. Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.International review of cell and molecular biology · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kristopher K FreseDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
Siu Sylvia Lee
Darby L Thomas
Isabel J Latorre
Robert S Weiss
Britt A Glaunsinger
Ronald T Javier
Baylor College of Medicine · USCornell University · USUniversity of California, San Francisco · US

Funding

ROLE OF THE AD9 E4 REGION IN MAMMARY GLAND ONCOGENESISR01CA058541 · NCI · BAYLOR COLLEGE OF MEDICINE · PI JAVIER, RONALD T. · 1993 to 2013
$3.9M
RESEARCH TRAINING PROGRAM IN MOLECULAR VIROLOGYT32AI007471 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI RAMIG, ROBERT FRANKLIN · 1996 to 2010
$2.6M
RESEARCH TRAINING PROGRAM IN VIRAL ONCOLOGYT32CA009197 · NCI · BAYLOR COLLEGE OF MEDICINE · PI MARRIOTT, SUSAN J · 1986 to 2003
$804k
NCI NIH HHS R01 CA058541NCI NIH HHS R01 CA58541NCI NIH HHS T32 CA009197NCI NIH HHS T32 CA09197NIAID NIH HHS T32 AI007471NIAID NIH HHS T32 AI07471
6 · The paper itself

Abstract

While PDZ domain-containing proteins represent cellular targets for several different viral oncoproteins, including human papillomavirus E6, human T-cell leukemia virus type 1 Tax, and human adenovirus E4-ORF1, the functional consequences for such interactions have not been elucidated. Here we report that, at the plasma membrane of cells, the adenovirus E4-ORF1 oncoprotein selectively and potently stimulates phosphatidylinositol 3-kinase (PI3K), triggering a downstream cascade of events that includes activation of both protein kinase B and p70S6-kinase. This activity of E4-ORF1 could be abrogated by overexpression of its PDZ-protein targets or by disruption of its PDZ domain-binding motif, which was shown to mediate complex formation between E4-ORF1 and PDZ proteins at the plasma membrane of cells. Furthermore, E4-ORF1 mutants unable to activate the PI3K pathway failed to transform cells in culture or to promote tumors in animals, and drugs that block either PI3K or p70S6-kinase inhibited E4-ORF1-induced transformation of cells. From these results, we propose that the transforming and tumorigenic potentials of the adenovirus E4-ORF1 oncoprotein depend on its capacity to activate PI3K through a novel PDZ protein-dependent mechanism of action.

Indexed as

Adenovirus E4 ProteinsAnimalsCell Cycle ProteinsChromonesCyclin-Dependent Kinase Inhibitor p27DNA-Binding ProteinsForkhead Box Protein O1Forkhead Transcription FactorsMammary Neoplasms, AnimalMorpholinesMutationNerve Tissue ProteinsPhosphatidylinositol 3-KinasesRatsRats, Inbred WFSirolimus2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneAdenovirus E4 ProteinsCdkn1b protein, ratCell Cycle ProteinsChromonesCyclin-Dependent Kinase Inhibitor p27DNA-Binding ProteinsForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, ratMorpholinesNerve Tissue ProteinsPhosphatidylinositol 3-KinasesSirolimusTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID12569363
PMCPMC3501958
OpenAlexW2079832429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.